Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/11/2025 ,inter alia, to consider and approve Pursuant to Regulation 29(1) ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dipna Pharmachem Ltd has informed BSE that its Board of Directors meeting, originally scheduled for 19th November 2025, has been rescheduled to 26th November 2025 at 4:30 PM due to unavoidable circumstances. The rescheduled meeting will be held at the company's registered office in Ahmedabad. The primary agenda is to consider and approve the Unaudited Financial Results for the half year ended 30th September 2025, along with the Limited Review Report. Any other matters may also be discussed with the Chairperson's permission.
This is a routine procedural update with no direct financial impact on shareholders. The one-week delay in approving and disclosing H1 FY26 results may slightly postpone visibility into the company's financial performance but is unlikely to materially affect the stock.